|83.44||-1.16 / -1.37%|
Data as of 4:00pm ET
|82.03||-1.41 / -1.69%|
The 6 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 106.50, with a high estimate of 147.00 and a low estimate of 80.00. The median estimate represents a +27.64% increase from the last price of 83.44.
The current consensus among 5 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.